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Summary 
The serine/threonine protein kinase encoded by the 
Akf proto-oncogene is catalytically inactive in serum- 
starved primary and immortalized fibroblasts. Here we 
show that Akt and the Akt-related kinase AKT2 are acti- 
vated by PDGF. The activation was rapid and specific, 
and it was abrogated by mutations in the Akt Pleckstrin 
homology (PH) domain. The Akt activation was also 
shown to depend on PDGFRp tyrosines Y740 and Y751, 
which bind phosphatidylinositol 3-kinase (PI 3-kinase) 
upon phosphorylation. Moreover, Akt activation was 
blocked by the PI 3-kinase-specific inhibitor wortman- 
nin and the dominant inhibitory N17Ras. Conversely, 
Akt activity was induced following the addition of 
phosphatidylinositol-3-phosphate to Akt immunopre- 
cipitates from serum-starved cells in vitro. These re- 
sults identify Akt as a novel target of PI 3-kinase and 
suggest that the Akt PH domain may be a mediator of 
PI 3-kinase signaling. 
Introduction 
Following ligand binding, tyrosine kinase receptors un- 
dergo dimerization leading to the activation of their intrin- 
sic tyrosine kinase activity and autophosphorylation. The 
tyrosine-phosphorylated regions of the receptor, in turn, 
function as high affinity binding sites for a series of Src 
homology 2 (SH2) domain- and phosphotyrosine-binding 
(PTB) domain-containing proteins (Cohen et al., 1995; 
Pawson, 1995), which, upon phosphorylation, transduce 
receptor-generated signals (Heldin, 1995). The receptor 
binding of these signaling proteins is site specific (Cohen 
et al., 1995; Pawson, 1995). Mutation of individual receptor 
autophosphorylation sites prevents the transduction of 
signals mediated by the molecules that bind to these sites 
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(Valius and Kazlauskas, 1993). On the basis of these ob- 
servations, it has been proposed that the unique specificity 
of individual receptors in a given cell type is determined 
by the sum of the activities of the signaling proteins that 
interact with the receptor in its tyrosine-phosphorylated 
form. Accordingly, the interaction of overlapping subsets 
of signaling proteins with different activated receptors initi- 
ates distinct, receptor-specific signaling cascades (Heldin, 
1995). 
Mitogenic signals are transmitted from the activated ty- 
rosine kinase receptors through several known pathways. 
One such pathway involves the activation of protein kinase 
C (PKC) (Divecha and Irvine, 1995); another, the activation 
of the mitogen-activated protein kinases (MAPK or ERK 
[for extracellular signal-regulated protein kinase]) (Mar- 
shall, 1995); a third, the phosphorylation and activation 
of the p70 s6k kinase (Downward, 1994); and a fourth, the 
tyrosine phosphorylation and nuclear translocation of a 
family of cytoplasmic transcription factors called STATs 
(for signal transducer and activator of transcription) (Hel- 
din, 1995). Triggering these pathways depends on direct 
protein-protein interactions, posttranslational modifica- 
tions, and the induction of second messenger molecules 
(Marshall, 1995; Divecha and Irvine, 1995). The synthesis 
of one class of such molecules involves the phosphoryla- 
tion of phosphatidylinositol and its D-4- and D-5-phosphor- 
ylated derivatives in the D-3 position, in a reaction cata- 
lyzed by the phosphatidylinositol 3-kinase (PI 3-kinase) 
(Kapeller and Cantley, 1994). Recent studies have shown 
that the PI 3-kinase exhibits both lipid and protein kinase 
activities (Kapeller and Cantley, 1994), activates the p70 s6k 
(Downward, 1994), and in many cell types, plays a critical 
role in mitogenic or other signaling (Kapeller and Cantley, 
1994). 
Akt (or c-akt), the cellular homolog of the viral oncogene 
v-akt, encodes a serine/threonine protein kinase that is 
ubiquitously expressed (Bellacosa et al., 1993) and whose 
catalytic domain is closely related to the catalytic domain 
of all the members of the PKC family (Bellacosa et al., 
1991). Akt, however, differs from other PKC family mem- 
bers in that it contains an N-terminal domain (amino acids 
1-147) (Akt homology [AH] domain) (Bellacosa et al., 
1991, 1993; Franke et al., 1994), part of which (amino 
acids 1-106) is related to the Pleckstrin homology (PH) 
domain, present in a large number of signaling molecules 
(Cohen et al., 1995). Recent studies from this laboratory 
have shown that the AH domain of Akt is a domain of 
protein-protein i teraction that mediates the formation of 
Akt multimeric omplexes and that the formation of these 
complexes is associated with protein kinase activation 
(Datta et al., 1995). Probing DNA from vertebrate and in- 
vertebrate species with an AH/PH domain probe revealed 
that Akt is a member of a conserved family of kinases 
(Cheng et al., 1992; Franke et al., 1994). In addition to 
Akt, this family includes the human AKT1/RACa and AKT2/ 
RAC,8 (Cheng et al., 1992), the Drosophila melanogaster 
Daktl (Franke et al., 1994), and at least two Caenorhab- 
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Figure 1. The Akt Kinase Is Activated by PDGF: Identification ofAkt 
Substrates 
(A) In vitro kinase assays of Akt immunoprecipitated, in the presence 
or absence of immunizing peptide (1 pM), from lysates of serum- 
starved or serum-starved and PDGF-stimulated (50 ng/ml PDGF-AB 
for 10 min) NIH 3T3 cells (left) or NIH 3T3, Rat-l, and MEF cells (right). 
Immunoprecipitations were carried out with the anti-Akt-CT antibody. 
The lower part of both panels shows an anti-Akt-CT Western blot of 
the immunoprecipitates used in the experiment. 
(B) Substrate specificity of Akt. Invitro phosphorylation f a panel of 
exogenous ubstrates (500 ng per reaction). 
(C) Kinase-defective Akt does not respond to PDGF. In vitro kinase 
assays of Akt immunoprecipitated with the anti-HA monoclonal nti- 
body 12CA5 from NIH 3T3 cells transiently transfected with HA-Akt 
or HA-Akt K179M. The exogenous ubstrate, histone H2B, was used 
at a concentration of0.1 mg/ml. The expression of the wild-type and 
mutant Akt proteins was monitored by probing a Western blot of the 
immunoprecipitates with the polyclonal nti-HA antibody. 
(D) Activation of AKT2 by PDGF. In vitro kinase assays ofAkt and 
AKT2 immunoprecipitated with the anti-HA monoclonal ntibody from 
NIH 3T3 cells transiently transfected with HA-Akt or HA-AKT2. Protein 
expression was monitored by probing a Western blot of the immuno- 
precipitates with the anti-Akt-CT antibody. 
ditis elegans genes (Waterston et al., 1992). Of these 
genes, AKT2/RAC,8 is amplified in approximately 10% of 
human ovarian neoplasms (Cheng et al., 1992). 
In this paper, we present evidence that Akt is activated 
rapidly and specifically following exposure of primary 
mouse embryo fibroblasts (MEFs), NIH 3T3 cells, and 
Rat-1 cells to platelet-derived growth factor (PDGF). The 
related kinases AKT2 and Daktl are also activated by 
PDGF. Genetic, pharmacological, and biochemical stud- 
ies revealed that the transduction of PDG F-generated Akt 
activation signals depends on the activation of the PI 
3-kinase and on the Akt AH/PH domain. In addition to 
defining a signal that activates the Akt kinase, these data 
also provide a function for the PI 3-kinase-generated D-3- 
phosphorylated phosphoinositides and suggest that the 
Akt AH/PH domain may be a mediator of PI 3-kinase sig- 
naling. 
Results 
PDGF Induces Akt Kinase Activity 
Previous studies had shown that the murine serine/threo- 
nine protein kinase Akt is ubiquitously expressed (Bella- 
cosa et al., 1993). However, Akt immunoprecipitated from 
serum-starved immortalized mouse and rat embryo fibro- 
blasts (NIH 3T3 and Rat-1 cells) as well as primary MEFs 
is catalytically inactive. Since PDGF is one of the major 
mitogens in serum (Stiles et al., 1979), we examined whether 
PDGF induced Akt protein kinase activity n serum-starved 
cells. NIH 3T3 cells were exposed to PDGF-AB (50 ng/ml) 
following 24 hr of serum starvation. After 10 min, the cells 
were lysed, and Akt was immunoprecipitated with a poly- 
clonal anti-Akt antiserum raised against a peptide com- 
posed of the 15 C-terminal amino acids of Akt (anti-Akt- 
CT). In parallel reactions, the immunoprecipitation f Akt 
was competed by excess immunizing peptide (1 I~M). Akt 
kinase activity was induced rapidly, following exposure to 
PDGF (Figure 1A, left). Moreover, Akt was activated by 
PDGF not only in NIH 3T3 but also in Rat-1 and MEF cells 
by using a similar protocol (Figure 1A, right). 
The end point in the assays, shown in Figure 1A, was 
the autophosphorylation f Akt. To identify a suitable exog- 
enous substrate, we carried out in vitro kinase reactions 
of Akt immunoprecipitated from serum-starved or serum- 
starved and PDGF-stimulated NIH 3T3 cells by use of the 
panel of proteins shown in Figure 1B. Among six proteins 
compared in this experiment, histone H2B was the most 
sensitive and specific Akt substrate. 
The PDGF-induced kinase activity could be due to the 
activation of Akt or to the activation of a coprecipitating 
protein kinase. To distinguish between these possibilities, 
we constructed a kinase-defective Akt mutant in which the 
lysine of the ATP-binding site at position 179 (Bellacosa 
et al., 1993) was replaced by a methionine (Akt K179M). 
Expression constructs of wild-type and kinase-defective 
Akt carrying a hemagglutinin (HA)-derived N-terminal epi- 
tope tag were transiently transfected into NIH 3T3 cells. 
The wild-type and the kinase-defective mutant Akt pro- 
teins were subsequently immunoprecipitated from serum- 
starved, transiently transfected cells before and after 
PDGF stimulation. PDGF activated only the wild-type Akt 
kinase. These results confirmed that the PDGF-induced 
protein kinase activity associated with the Akt immunopre- 
cipitates was due to the activation of Akt. 
To determine Whether the human Akt-related kinase 
Akt Activation by PDGF via PI 3-Kinase 
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Figure 2. Akt Is Activated Rapidly and Specifically by PDGF 
(A) The activation of Akt by PDGF is growth factor-specific. NIH 3T3 
cells were serum-starved overnight and then exposed for 10 rain to a 
panel of growth factors as indicated. 
(B) Time course of Akt activation by PDGF in serum-starved (time 0) 
or serum-starved and PDGF-stimulated NIH 3T3 cells. The lower parts 
of both panels show Western blots of total cell lysates, probed with 
the anti-Erk antibody. 
AKT2 was also activated by PDGF, we transiently 
transfected NIH 3T3 cells with HA epitope-tagged AKT2 
expression constructs. AKT2 immunoprecipitated from 
the transfected cells with the anti-HA monoclonal antibody 
12CA5 was activated by PDGF (Figure 1 D). The expres- 
sion of the transiently transfected HA-AKT2 construct was 
confirmed by probing a Western blot of the anti-HA immu- 
noprecipitates with the anti-Akt-CT antibody (Figure 1D). 
In similar experiments, the closest homolog of Akt in hu- 
mans, AKT1, and the Drosophila homolog Daktl were also 
activated by PDG F (data not shown). Moreover, the protein 
encoded by the viral oncogene v-akt was shown to exhibit 
basal kinase activity and enhanced responsiveness to 
PDGF stimulation (T. F. F. and P. N. T., unpublished ata). 
Akt Kinase Activity Is Induced Rapidly and 
Specifically by PDGF 
To determine the specificity of the PDGF-induced activa- 
tion of Akt, we carried out in vitro kinase assays using 
Akt immunoprecipitates from serum-starved NIH 3T3 cells 
before and after exposure to PDGF-AA, PDGF-BB, PDGF- 
AB, epidermal growth factor (EGF), fibroblast growth fac- 
tor (FGF), and phorbol-12-myristate-13-acetate (PMA). 
The results (Figure 2A) revealed that the PDGF-induced 
activation of Akt is highly specific, in that it is induced by 
all three isoforms of PDGF but not by the other tested 
factors, The failure of EGF, FGF, and PMA to induce the 
activation of Akt could be due to the failure of the NIH 3T3 
cells to respond to these factors. To test this possibility, 
we examined the SDS-polyacrylamide gel electrophore- 
sis migration of the MAP kinases p44 Erkl and p42 Erk2, in the 
same lysates used for the in vitro kinase assays in Figure 
2A, by Western blot analysis using a polyclonal anti-Erk 
antiserum. EGF, FGF, and PMA each induced MAPK size 
shifts diagnostic of MAPK activation (Figure 2A) (Marshall, 
1995). Therefore, the failure of these factors to induce Akt 
activation was not due to their inability to stimulate the 
NIH 3T3 cells. 
Subsequently, we examined the kinetics of Akt activa- 
tion following exposure of serum-starved NIH 3T3 cells to 
PDGF at room temperature and at 4°C. Figure 2B shows 
the time course of Akt activation at room temperature. Akt 
was activated within 1 rain, with maximum activity reached 
within 3 min of exposure to PDGF. A delay in Akt activation 
(3 min) was observed when the stimulation was carried 
out at 4°C (data not shown). Western blot analyses of the 
cell lysates in Figure 2B, using the anti-Erk antiserum, 
showed that the PDGF-induced MAPK size shift was de- 
layed relative to the PDGF-induced activation of Akt. De- 
spite the rapidity of activation of Akt, however, immunopre- 
cipitations of the PDGF receptor (PDGFR) or of Akt from 
lysates of PDGF-stimulated NIH 3T3 cells failed to show 
a direct association between the two molecules (data not 
shown). 
The PDGF-Induced Activation of Akt 
Is AH/PH Domain Dependent 
Given that the AH/PH domain is a characteristic feature 
of all the Akt family members (Cheng et al., 1992; Franke 
et al., 1994) and that all the known members of this family 
are activated by PDGF (this paper), we examined whether 
the AH/PH domain may be mediating PDGF-induced Akt 
signals. Constructs of two mutants, one carrying an argi- 
nine to cysteine mutation at am ino acid 25 (HA-Akt R25C) 
and another carrying a deletion of amino acids 11-35 (HA- 
Akt 411-35), were transiently transfected in NIH 3T3 cells. 
In vitro kinase assays of the two mutants immunoprecipi- 
tated from lysates of serum-starved or serum-starved and 
PDGF-stimulated cells revealed that both fail to respond 
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Figure 3. Mutations inthe AH/PH Domain of Akt Abolish Akt Activation 
In vitro kinase assays of Akt immunoprecipitated with the monoclonal 
anti-HA antibody from NIH 3T3 cells transiently transfected with the 
indicated HA-tagged Akt constructs. Expression of the transfected con- 
structs was assessed by probing aWestern blot of the immunoprecipi- 
tates with the anti-HA antiserum. 
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Figure 4. Akt Activation Is Mediated by Y740 and Y751 of the PDGFRI3 
(A) Y740 and Y751 of the PDGFR~ (~-PDGF-R) are required for Akt activation. In vitro kinase assays of Akt immunopreclpitated with the anti-HA 
monoclonal antibody from TRMP cells transiently transfected with HA-Akt and pMT3 vector DNA, or the indicated pMT3-based PDGF receptor 
constructs. The cells were stimulated with PDGF-AB (400 ng/ml for 5 rain) following overnight serum starvation. 
(B) Y740 and Y751 in the context of the F5 mutant are sufficient for Akt activation. In vitro kinase assays of Akt immunoprecipitated with the 
anti-HA monoclonal antibody from TRMP cells transiently transfected with HA-Akt and the indicated PDGFR~ constructs. The cells were stimulated 
with PDGF-BB (400 ng/ml) following overnight serum starvation. 
(C) Tyrosine to phenylalanine mutations at position 740 (F740) or 751 (F751) of the PDGFRI3 do not abolish Akt activation. In vitro kinase assays 
of Akt immunoprecipitated with the anti-HA monoclonal antibody from TRMP cells stably transfected with PDGFRI3 mutants, as indicated, and 
supertransfected transiently with HA-Akt. The cells were stimulated with PDGF-BB (400 ng/ml) following overnight serum starvation. 
(D) Src is not required for Akt activation. In vitro kinase assays of Akt immunoprecipitated with the anti-HA monoclonal antibody from primary 
MEFs and SV40-transformed MEFs from Src knockout mice (Src6), transiently transfected with HA-Akt. Following overnight serum starvation, 
the cells were stimulated with PDGF-AB (50 ng/ml). 
to PDGF stimulation (Figure 3). The R25C mutation was 
tested because a comparable mutation (R28C) in the PH 
domain of Bruton's tyrosine kinase (Btk) had been shown 
to be responsible for the induction of X-linked immunodefi- 
ciency in CBA/N mice (Rawlings et al., 1993). To deter- 
mine whether these AH/PH mutations affected the basal 
kinase activity of Akt, we overexpressed the wild-type and 
mutant proteins in COS1 cells, and following serum starva- 
tion, we examined their kinase activity. The results (data 
not shown) revealed that he mutant proteins continued 
to exhibit kinase activity. Therefore, the AH/PH mutations 
did not affect the ability of these proteins to function as 
protein kinases. 
The Activation of Akt by PDGF Requires Signals 
That Depend upon the PDGFRI~ Tyrosines 
740 and 751 
To define the signaling pathway responsible for the PDGF- 
induced activation of Akt, we cotransfected canine kidney 
epithelial TRMP cells, which do not express PDGFR (Val- 
ius and Kazlauskas, 1993), with wild-type or mutant 
PDGFR and HA epitope-tagged Akt constructs. Following 
PDGF stimulation, Akt was immunoprecipitated from the 
transfected cells by use of the monoclonal anti-HA tag 
antibody. In vitro kinase assays of the Akt immunoprecipi- 
tates, shown in Figure 4A, revealed that both the a and 
the 15 subunits of the human PDGFR (Heldin, 1995) trans- 
duce Akt activation signals. However, the kinase-defective 
PDGFRI3 mutant M635R and another mutant, whose two 
tyrosine phosphorylation sites Y740 and Y751 had been 
mutated into phenylalanines (F2), failed to transmit PDGF 
signals leading to Akt activation. The phosphorylation of 
the PDGFRI3 tyrosine Y751 generates a high affinity bind- 
ing site for Nck (Heldin, 1995), while the phosphorylation 
of tyrosines Y740 and Y751 generates a high affinity bind- 
ing site for the p85 regulatory subunit of the PI 3-kinase 
Akt Activation by PDGF via PI 3-Kinase 
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(Heldin, 1995). These data suggested, therefore, that the 
transduction of PDGF-induced Akt activation signals de- 
pends on the interaction of the activated PDGFR with PI 
3-kinase, Nck, or both. 
To confirm and extend these results, we repeated the 
experiment in Figure 4A but used the wild-type PDGFRI3; 
a PDGFRI3 mutant whose tyrosine phosphorylation sites 
Y740, Y751, Y771, Y1009, and Y1021 had been mutated 
into phenylalanines (F5 mutant) (Valius and Kazlauskas, 
1993); and three F5 phenylalanine to tyrosine add-back 
revertants (YY740/51, Y751, and Y771). The tyrosine 
phosphorylation sites Y771, Y1009, and Y1021 direct the 
binding of rasGAP, Syp, and phospholipase C (PLC)-y1 to 
PDGFRI~, respectively (Heldin, 1995). The results (Figure 
4B) revealed that full activation of Akt required tyrosine 
residues at both the 740 and 751 positions. The phenylala- 
nine to tyrosine mutation at position 751 could partially 
reconstitute the ability of the receptor to activate Akt follow- 
ing PDGF stimulation. Finally, the Y771 revertant was 
identical to the F5 mutant with regard to its inability to 
activate Akt. Both the HA-Akt and the PDGFR constructs 
were expressed in the transfected cells. Moreover, both 
the e and 13 subunits of the PDGFR as well as all the 
mutants of the PDGFRI3, with the exception of M635R, 
responded to PDGF stimulation with tyrosine autophos- 
phorylation (Figures 4A and 4B). Therefore, the failure of 
some of the mutant receptors to activate Akt was not due 
to lack of expression or to lack of PDGF receptor activity. 
The results of the experiment in Figure 4B were con- 
firmed by additional experiments utilizing TRMP cells sta- 
bly transfected with expression constructs of PDGFRI3 m u- 
tants in which the tyrosines Y740, Y751, or Y1009 and 
Y1021 had been changed into phenylalanines. The end 
point in these experiments was the activation of the Akt 
protein kinase encoded by a transiently transfected HA- 
Akt expression construct. The results (Figure 4C) showed 
that PDGFRI~ constructs with tyrosine to phenylalanine 
mutations at position 740 or 751 encoded proteins that 
were able to transmit PDGF-induced Akt activation sig- 
nals. TRMP cells stably transfected with PDGFRI3 con- 
structs, carrying tyrosine to phenylalanine mutations at 
positions Y1009 and Y1021, were also shown to respond 
to PDG F with full activation of the Akt kinase. These results 
confirmed the results of the preceding experiments. More- 
over, they suggested that the phosphotyrosine phospha- 
tase Syp and PLC-~,I, which bind to tyrosines Y1009 and 
Y1021, respectively (Heldin, 1995), are not involved in the 
activation of Akt. Finally, given that the mutant F751 re- 
tains the ability to transduce Akt activation signals, these 
data suggested that it is unlikely for Nck, which binds to 
phosphorylated Y751 (Heldin, 1995), to contribute to this 
process. 
In addition to the PDGFRI3 tyrosines mutated in the F5 
mutant, other tyrosines involved in PDGF signaling are 
the tyrosines at positions 579 and 581. These tyrosines 
define the high affinity binding site for Src (Heldin, 1995). 
To determine whether S c is involved in the PDGF-induced 
activation of Akt, we could not use phenylalanine to tyro- 
sine receptor mutants at this site, because these mutants 
lack tyrosine kinase activity (Heldin, 1995). To address this 
question, we used a large T antigen-immortalized mouse 
embryo fibroblast cell line derived from Src  knockout mice 
(Soriano et al., 1991). PDGF stimulation induced full acti- 
vation of the Akt kinase (Figure 4D). Although it may be 
possible that other Src-like kinases can substitute for Src 
in these cells (Heldin, 1995), these data suggest that it is 
unlikely for Src to play an important role in Akt activation. 
The data shown in Figure 4 therefore collectively suggest 
that the major factor responsible for the PDGF-induced 
activation of Akt is the activation of the PI 3-kinase. 
PDGF-Induced Akt Activation Is 
Inhibited by Wortmannin 
The preceding results suggested that Akt activation is PI 
3-kinase dependent, However, it is possible that Akt acti- 
vation signals might be transduced by other proteins inter- 
acting with tyrosines Y740 or Y751 of the PDGFR~, To 
address the role of the PI 3-kinase further, we examined 
the effects of the PI 3-kinase inhibitor wortmannin on the 
PDGF-induced Akt activation, Wortmannin at nanomolar 
concentrations is known to inhibit only the PI 3-kinase, 
whereas at micromolar concentrations, italso inhibits pro- 
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Figure 5. Wortmannin, but Not Rapamycin, Inhibits PDGF-Induced 
Akt Activation 
(A) In vitro kinase assays of Akt immunoprecipitated from serum- 
starved NIH 3T3 cells treated with wortmannin orrapamycin dissolved 
in DMSO, or with DMSO only. Following treatment, all the cultures, 
with the exception of one that had been treated with DMSO only (first 
lane), were stimulated with PDGF-AB (50 ng/ml). Alternatively, wort- 
mannin (100 nM) was added in vitro to lysates of NIH 3T3 cells stimu- 
lated with PDGF-AB (third lane, marked by asterisk). Anti-p70 sS~ and 
anti-Erk antibodies were used to probe Western blots of NP-40 lysates 
from the same cells. 
(B) PI 3-kinase assays were performed on NP-40 lysates from cells 
treated with wortmannin or rapamycin i  parallel with the cells in (A). 
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Figure 6. The Activation of Akt Is Inhibited by Dominant Inhibitory N17Ras, but Akt Fails to Activate the MAPK 
(A) Dominant inhibitory N17Ras inhibits Akt activation. In vitro kinase assays of Akt immunoprecipitated with the monoclonal anti-HA antibody 
from NIH 3T3 cells transiently transfected with HA-Akt or HA-Akt and N17Ras in the expression vector pCMV-5. 
(B) V12Ras does not activate Akt, In vitro kinase assays of Akt immunoprecipitated using the anti-Akt-CT antiserum from serum-starved or serum- 
starved and PDGF-treated fibroblasts or NIH 3T3 cells transformed by V12Ras. 
(C) Akt does not induce MAPK activity, COS1 cells were transfected with Myc epitope-tagged MAPK (MT-p44) and v-akt or the indicated HA 
epitope-tagged Akt constructs. Akt and MAP kinase activities were examined in serum-starved or serum-starved and EGF-stimulated cells (100 
ng/ml for 10 min). 
tein kinases (Powis et al., 1994). NIH 3T3 cells were pre- 
treated with increasing concentrations of wortmannin 
(0.5-500 nM) prior to PDGF stimulation. Alternatively, wort- 
mannin was added in vitro to lysates of PDGF-stimulated 
NIH 3T3 cells (100 nM). Wortmannin inhibited Akt activa- 
tion in vivo at concentrations imilar to the ones inhibiting 
the PI 3-kinase (Powis et al., 1994). However, wortmannin 
failed to inhibit Akt in vitro (Figure 5A), suggesting that, 
at the concentrations used, it has no direct inhibitory ef- 
fects on the activity of Akt. 
The tyrosine kinase receptor-mediated activation of the 
PI 3-kinase leads to the activation of the p70 s6k by a pro- 
cess that is inhibited not only by the PI 3-kinase inhibitor 
wortmannin but also by the macrolide antibiotic rapamycin 
(Downward, 1994). Rapamycin inactivates the PI 3-kinase- 
related protein RAFT1 (for rapamycin and FKBP12 target 
1) by promoting its binding to FKBP12 (Sabatini et al., 
1994). To determine whether Akt functions upstream or 
downstream of RAFT1 in the pathway leading to the activa- 
tion of the p70 s6k, we examined the effects of rapamycin 
on the PDGF-induced activation of Akt. The results 
showed that rapamycin does not inhibit Akt (Figure 5A). 
Therefore, the activation of Akt is independent of RAFT1. 
Subsequently, we examined the effects of wortmannin 
and rapamycin on the activity of the PI 3-kinase in the 
serum-starved or serum-starved and PDGF-stimulated 
NIH 3T3 cells utilized in the preceding experiment. PI 
3-kinase assays carried out as described in the Experi- 
mental Procedures showed that wortmannin concentra- 
tions inhibiting the PDGF-induced activation of Akt also 
blocked the activity of the PI 3-kinase, whereas rapamycin 
had no effect on the activity of either (Figure 5B). There- 
fore, the activation of the PI 3-kinase and Akt by PDGF 
appear to be functionally linked. 
PDGF-Induced Activation of Akt 
Is Inhibited by N17Ras 
GTP-bound c-Ha-Ras interacts with the catalytic subunit 
of the PI 3-kinase and contributes to its activation (Rodri- 
guez-Viciana et al., 1994). In accordance with this, the 
dominant negative mutant of c-Ha-Ras, N17Ras, blocks 
the receptor-mediated activation of the PI 3-kinase (Rodri- 
guez-Viciana et al., 1994). To test whether Akt is a down- 
stream target of the PI 3-kinase, we also examined 
whether its activation by PDGF was inhibited by the domi- 
nant negative mutant of c-Ha-Ras, N17Ras. To this end, 
we examined the kinase activity of HA epitope-tagged Akt 
before and after PDGF stimulation following cotransfec- 
tion of N17Ras and HA-Akt. N17Ras partially blocks the 
PDGF-induced activation of Akt (Figure 6A). To determine 
whether c-Ha-Ras was sufficient o induce Akt activation, 
we examined the kinase activity of the endogenous Akt 
protein, before and after PDGF stimulation, in NIH 3T3 
cells stably transfected with a construct of the activated 
form of c-Ha-Ras, V12Ras. V12Ras was not sufficient o 
activate Akt in the absence of PDGF (Figure 6B). This 
result may be due to the activation of the PI 3-kinase by 
V12Ras at levels below the threshold necessary for Akt 
activation (Rodriguez-Viciana et al., 1994). Alternatively, 
it may be due to the fact that the activation of Akt by PDGF 
may be mediated by both Ras-dependent and Ras- 
independent signals. 
The Ras-dependent activation of Akt shown in Figure 
6A suggested that Akt may be a member of a signaling 
pathway that activates the MAP kinase (Marshall, 1995). 
To address this question, we tested the ability of overex- 
pressed, enzymatically active v-akt and HA-Akt to activate 
MAPK in COS1 cells. EGF stimulation was used as a posi- 
tive control, and the kinase-defective mutant of Akt (HA- 
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Figure 7. In Vitro Activation of Akt Activity by PIP 
(A) Akt immunoprecipitated from lysates prepared from serum-starved 
or serum-starved and PDGF-stimulated NIH 3T3 cells is activated by 
PIP (PI-3-P) but not PI or PIP2 (PI-4,5-P2). 
(B) Activation of Akt by PIP generated by PI 3-kinase immunoprecipi- 
rated either with anti-PI 3-kinase or with anti-PY. 
(C) Akt activity is induced by PIP in a dose-dependent manner. Increas- 
ing concentrations ofenzymatically produced PIP were added to Akt 
from serum-starved NIH 3T3 cells. PIP was diluted in PI carrier. Akt 
activity in the presence of PIP plus PI carrier relative to its activity in 
the presence of PI only was as follows: PI plus 10 -2 PIP, 2.51 x; PI 
plus 10 -1 PIP, 4.54x; PIP, 4.49x. 
Akt K179M) was used as a negative control. Even though 
v-akt and HA-Akt were active as determined by the ability 
of the immunoprecipitated proteins to phosphorylate his- 
tone H2B, they both failed to activate MAPK (Figure 6C). 
Oncogenic v-raf and V12Ras induced MAP kinase activity 
in parallel experiments (data not shown). Furthermore, 
MAPK was not activated in NIH 3T3 cells expressing v-akt 
(data not shown). 
Akt Is Activated by PIP In Vitro 
The data presented in this manuscript indicate that the 
PDGF-induced activation of Akt depends upon the integ- 
rity of its AH/PH domain, and upon the activation of the 
PI 3-kinase. Moreover, recent studies have shown that 
phosphatidylinositol 4,5-bisphosphate (PIP2, also referred 
to as PI-4,5-P2) binds to the PH domain of pleckstrin (Co- 
hen et al., 1995). This observation, combined with our 
genetic and pharmacological data, suggested that Akt 
may be activated through the interaction between its AH/ 
PH domain and PI 3-kinase-generated D-3-phosphory- 
lated phosphoinositides. To test this hypothesis, we car- 
ried out in vitro kinase assays of Akt immunoprecipitated 
from serum-starved NIH 3T3 cells, in the presence of phos- 
phatidylinositol (PI), PIP2, and enzymatically synthesized 
phosphatidylinositol 3-phosphate (PIP, also referred to as 
Table 1. Induction of Akt Activation by Phosphorylated PI Using PI 
as a Carrier 
Phospholipid Added In Vitro Fold Activation 
Mock treated 1.58 _+ 0.56 
PI 1 
Undiluted PIP 4.37 _ 2.36 
PI plus 10 -1 PIP 2.57 + 1.32 
PI plus 10 -2 PIP 1.54 _+ 0.56 
PI plus 10 -3 PIP 1.34 _+ 0.01 
PI plus 10 -4 PIP 1.05 -+ 0.04 
Akt was immunoprecipitated from serum-starved NIH 3T3 cells by use 
of anti-Akt-CT. After washing, immunoprecipitates w re divided 
equally and treated with 30 mM HEPES (pH 7.4) (mock), sonicated 
PI, or PIP as indicated. PIP generated enzymatically, using PI as the 
substrate, was used either directly or after dilution in carrier PI as 
indicated. Mean and standard eviation values were calculated on the 
basis of five experiments, with the exception of the 104 and 10 -4 val- 
ues, which were calculated on the basis of the results of three experi- 
ments. In all experiments PI was given a value of 1.Quantitation of 
experiments was performed with a Phosphorimager. 
PI-3-P) (Experimental Procedures). While PI or PIP2 ap- 
peared to suppress Akt activity, PIP activated the Akt ki- 
nase in vitro (Figure 7A; Table 1). To confirm that the en- 
zyme immunoprecipitated from PDGF-stimulated cells 
was the PI 3-kinase, the experiment in Figure 7A was re- 
peated using anti-phosphotyrosine (anti-PY) or anti-p85 
immunoprecipitates. The proteins immunoprecipitated 
with both antibodies phosphorylated PI (data not shown), 
and the products of both reactions induced Akt activation 
(Figure 7B). Serial dilutions of enzymatically produced PIP 
(using PI as a carrier) induced the activation of Akt in a 
dose-dependent manner (Figure 7C; Table 1). Owing to 
the suppression of Akt activity by PI, however, the induc- 
tion of Akt activation by PIP appeared to be partially 
masked. Perhaps because of this and variations in the 
stoichiometry of phosphorylation of PI to PIP between ex- 
periments, the ability of different preparations of PIP to 
activate Akt in vitro varied (Table 1). 
Discussion 
In this paper, we have shown that the product of the c-akt 
proto-oncogene is specifically activated by PDGF. To de- 
termine the mechanism for PDGF-induced Akt activation, 
we expressed the wild-type PDGFR and a series of 
PDGFRp tyrosine mutants in PDGFR-negative TRMP 
cells. Akt activity was examined in these cells before and 
after PDGF stimulation. The results showed that tyrosines 
Y740 and Y751, which upon autophosphorylation form a 
high affinity binding site for the p85 regulatory subunit of 
the PI 3-kinase (Heldin, 1995), are required for PDGF- 
induced Akt activation. These results suggested that Akt 
may be a downstream target of the PDGF-activated PI 
3-kinase. Additional studies supporting this hypothesis 
showed that the activation of Akt by PDGF is abrogated 
by the PI 3-kinase inhibitor wortmannin (Powis et al., 1994) 
and by the dominant negative mutant of c-Ha-Ras, 
N 17Ras. However, the activation of Akt was not abrogated 
by rapamycin (Figure 8), a macrolide antibiotic that inacti- 
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Figure 8. A Model for Akt Activation by PDGF 
PDGF- and Ras-dependent activation of the PI 3-kinase induces PIP 
(PI=3-P), which activates Akt perhaps via binding to the Akt PH domain 
(see Discussion for details), 
vates the PI 3-kinase homolog RAFT1 by promoting its 
interaction with FKBP12 (Sabatini et al., 1994). Mutational 
analysis of Akt revealed that the AH/PH domain is required 
for its PI 3-kinase-dependent activation. These results, 
combined, suggested that the PDGF-mediated activation 
of Akt may be due to conformational changes induced by 
the interaction of Akt with phosphoinositides phosphory- 
lated in the D-3 position by the PDGF-activated PI 3-kinase. 
The ability of D-3-phosphorylated phosphoinositides toac- 
tivate Akt was confirmed by in vitro kinase assays that 
examined the activity of Akt immunoprecipitated from se- 
rum-starved NIH 3T3 cells in the presence or absence of 
exogenously added phosphoinositides. The activation of 
Akt and perhaps other members of the Akt family of ki- 
nases via their interaction with this class of phospholipids 
is particularly interesting in light of the relationship of the 
Akt and PKC kinase families (Bellacosa et al., 1991). 
These findings, therefore, reinforce the concept that the 
two families are ancestrally related and that they may have 
been evolutionarily separated to optimize their response 
to different second messenger lipids. 
The N-terminal 147 amino acids of Akt define a domain 
that is conserved among Akt molecules (the AH domain) 
(Franke et al., 1994) and whose 106 N-terminal amino 
acids exhibit homology with the PH domain (Cohen et al., 
1995). Recently, the solution structure of the PH domains 
of pleckstrin and I~-spectrin and the crystal structure of 
the PH domain of dynamin were determined (Cohen et 
al., 1995). All three structures revealed that the N-terminal 
portion of the PH domain forms a hydrophobic pocket con- 
sisting of seven antiparallel I~ sheets, whereas its C-ter- 
minal portion forms an amphipathic ~ helix that may cap 
the pocket. This structure suggested that PH domains may 
interact with lipids and perhaps other hydrophobic ligands. 
Support for this hypothesis was provided by experiments 
showing that PIP2 binds the PH domain of pleckstrin (Co- 
hen et al., 1995) and by earlier studies suggesting that 
the PH domain of PLC-$1 may be involved in the binding 
of the enzyme to lipid bilayers containing PIP2 (Cifuentes 
et al., 1994). Viewed in the context of these observations, 
our data suggest hat the PI 3-kinase-dependent activation 
of Akt may be due to the direct interaction of PIP with the 
hydrophobic pocket of the Akt AH/PH domain. We cannot, 
however, exclude the possibility that minor phospholipid 
products of the P I 3-kinase or of other enzymes coimm uno- 
precipitated with the PI 3-kinase contribute to the activa- 
tion of Akt in our assay system. To confirm these results, 
it will therefore be necessary to use purified or synthetic 
phospholipids as they become available (Divecha and Ir- 
vine, 1995). 
Our earlier studies had shown that Akt forms multimeric 
complexes through the interaction between AH domains 
and that the formation of such complexes may be associ- 
ated with the activation of the Akt kinase (Datta et al., 
1995). The PH domain alone fails to form complexes, sug- 
gesting that the interaction between Akt molecules de- 
pends on the integrity of the entire AH domain. Additional 
studies from other laboratories support the concept that 
PH domains are involved in protein-protein interactions 
(Touhara et al., 1994; Yao et al., 1994). These findings, 
combined with the results presented in this manuscript, 
suggest that PH domains may exert a dual function. Thus, 
Akt may interact with other proteins via its AH/PH domain, 
bringing it in close proximity to D-3-phosphorylated phos- 
phoinositides and other hydrophobic molecules. 
The specificity of Akt activation by PDGF was somewhat 
unexpected in view of the findings suggesting that Akt is 
activated as a result of the interaction of D-3-phosphor- 
ylated phosphoinositides with the AH/PH domain. Indeed, 
D-3-phosphorylated phosphoinositides are induced not 
only by PDGF but also by growth factors (Kapeller and 
Cantley, 1994) th at do not activate Akt. This could be owing 
to the relatively higher levels of D-3-phosphorylated phos- 
phoinositides generated by PDGF than by other growth 
factors, or to differences in the composition or subcellular 
distribution of phosphoinositides observed in cells treated 
with different factors (Kapeller and Cantley, 1994). Alterna- 
tively, different growth factors may activate PI 3-kinase 
enzymes that may vary with regard to their enzymatic prop- 
erties, regulation, and subcellular distribution (Kapeller 
and Cantley, 1994). In addition, Akt activation may require 
the contribution of multiple signaling pathways. Thus, 
whereas the dominant inhibitory N17Ras inhibits Akt acti- 
vation by PDGF, the activated V12Ras is not sufficient o 
stimulate Akt. While we cannot exclude the possibility that 
Vl 2Ras fails to stimulate Akt because it is a weak activator 
of the PI 3-kinase (Rodriguez-Viciana et al., 1994), these 
results suggest that other signals initiated by PDGF may 
act in concert with Ras to induce Akt activity. 
The specificity of Akt activation by PDGF suggests that 
Akt may transduce signals that distinguish PDGF from 
other growth factors. Therefore, the characterization of 
the signals transduced by activated Akt may provide signif- 
icant insight into the specificity of the cellular esponse to 
growth factors. Our data to date indicate that Akt fails to 
activate the MAP kinase cascade despite the fact that its 
activation depends, at least in part, on Ras-rnediated sig- 
nals. This suggests, therefore, that Akt functions in a Ras- 
dependent pathway that is independent of the MAP ki- 
nases. One such pathway involving MEKK and the JNK 
kinases was indeed recently described (Marshall, 1995). 
The data presented in this report also show that PDGF 
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activates not only the rodent Akt but also the human AKT2. 
In addition, data not shown indicate that PDGF activates 
all the known members of the Akt family of kinases, includ- 
ing the human AKT1 and the Drosophila Daktl .  AKT2 has 
been previously shown to be amplified and overexpressed 
in about 10% of ovarian neoplasms (Cheng et al., 1992). 
Moreover, it has been shown that the expression of 
PDGFR(~ is frequently elevated in ovarian tumors and that 
enhanced expression of PDGFR(z is associated with poor 
prognosis (Henriksen et al., 1993). Our data therefore indi- 
cate the need for future studies to address the combined 
effects of Akt and PDGFR overexpression on the induc- 
tion, progression, and prognosis of human ovarian tumors. 
Overall, the studies presented in this report show that 
the PH domain is required for the enzymatic activation 
of Akt in response to signals originating in the PDGFR. 
Moreover, they show that Akt activation may be mediated 
by second messenger molecules generated via the PDGF- 
induced activation of the PI 3-kinase. These findings de- 
fine a specific signal that activates Akt, identify a target 
for the PI 3-kinase, and implicate the Akt AH/PH domain 
as a mediator of PI 3-kinase signaling. 
Experimental Procedures 
Cells 
NIH 3T3, Rat-l, and NIH 3T3 cells transformed byV12Ras (provided by 
F. McCormick) were cultured in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% calf serum, penicillin (10 IU/ml), and 
streptomycin (10 ~g/ml). Untransfected canine kidney epithelial TRMP 
cells (provided by J. Cooper) and COS1 cells were cultured in the 
same medium supplemented with 10% fetal calf serum (FCS) and 
antibiotics. TRMP cells stably transfected with PDGFRI3 mutant con- 
structs (F740, F751, and FF1009/21)(also provided by J. Cooper)were 
maintained in the same media supplemented with G418 (200 i~g/ml). 
MEFs and SV40 large T antigen-transformed embryo fibroblasts from 
Src knockout mice (Src6) (provided by P. Soriano) were grown in 
DMEM supplemented with 15% FCS and antibiotics. To carry out 
experiments requiring serum starvation, cells were washed twice with 
Dulbecco's phosphate-buffered saline (PBS), following which they 
were cultured in serum-free DMEM overnight. The next day, cells were 
stimulated with growth factors at the concentrations indicated in the 
Results section and figure legends. PDGF-AA, PDGF-AB, PDGF-BB, 
and EGF were purchased from GIBCO BRL, FGF from Promega, PMA 
and wortmannin from Sigma, and rapamycin from Calbiochem. 
Plasmids 
R25C and K179M Akt mutants were generated by site-directed muta- 
genesis using the polymerase chain reaction (PCR) (Ito et aJ., 1991). 
The A11-35 deletion mutant of Akt was generated by overlap exten- 
sion PCR (He et al., 1989), HA-tagged Akt proteins were expressed 
in various cell lines, as indicated in the Results section, by transient 
transfection of pCMV-6 (provided by J. Chernof0 constructs. HA-Akt 
was transferred to the pCMV-6 vector as a HindllI-EcoRI DNA frag- 
ment from preexisting pJ3E~ constructs (Datta et al., 1995), HA-Akt 
K179M, HA-Akt R25C, and HA-Akt A11-35 pCMV-6 constructs were 
generated by exchanging a 1.5 kbp XbaI-Bam HI DNA fragment repre- 
senting the entire Akt coding region in the HA-Akt construct with the 
corresponding mutant DNA fragments. The Xbal and BamHI sites in 
the mutant DNA fragments were generated by PCR. The HA-AKT2 
construct was generated as described for HA-Akt. The v-akt construct 
in pJ3~ has been described previously (Ahmed et al., 1993). 
The SV-40-based vector pMT3 and expression constructs of 
PDGFRm PDGFR~, F5 PDGFRJ3 mutant (carrying tyrosine to phenylal- 
anine mutations at positions 740, 751, 771, 1009, and 1021), and 
M635R kinase-defective PDGFR~ mutant in the pMT3 vector have 
been previously reported (Kazlauekas and Cooper, 1989; Valius and 
Kazlauskas, 1993). Also previously reported were the YY740/51 and 
Y771 revertants of the F5 mutant and the F2 mutant of the PDGFRJ3 
(carrying tyrosine to phenylalanine mutations at positions 740 and 751) 
(Valius and Kazlauskas, 1993; Kazlauskas et al., 1992). The Y751 
revertant of the F5 mutant was generated by PCR site-directed muta- 
genesis. All the mutants provided or generated in vectors other than 
pMT3 were transferred to the pMT3 vector, which was used in all the 
transfection experiments. 
The Myc epitope-tagged Erkl (MT-p44) and the N17Ras expres- 
sion constructs were described elsewhere (Patriotis et al., 1994). 
Transfections 
Transient ransfections of fibroblast cell lines and TRMP cells seeded 
in 10 cm petri dishes at a density of 106 ceils per dish were carried 
out by using 10 ~_g of DNA per dish and lipofectamine (GIBCO BRL) 
according to the protocol suggested by the manufacturer. After 24 hr, 
the cells were serum-starved overnight. Later, 48 hours after transfec- 
tion, cells were exposed for 5-10 min to PDGF. Transient ransfections 
of COS1 cells were carried out by using the DEAE-dextran method 
as previously described (Datta et ai., 1995). 
Antibodies 
The anti-Akt-CT antibody was raised against a peptide composed of 
the 15 C-terminal amino acids of Akt (RPHFPQFSYSASGTA). Anti- 
Myc tag (anti-MT) monoclonal antibody was prepared by centrifugation 
of ascites fluid arising in mice inoculated intraperitoneally with the 
antibody producing hybridoma 9E10 (American Type Culture Collec- 
tion). Anti-HA monoclonal (12CA5) and polyclonal antibodies were pur- 
chased from BabCo (Berkeley Antibody Company). The rabbit anti- 
p70 sak polyclonal antibody was a gift from J. Blenis. The rabbit anti-p85 
serum was provided by L Cantley. The rabbit anti-Erk polyclonal anti- 
body was purchased from Santa Cruz Biotechnology, Incorporated. 
The rabbit anti-PDGFR~/PDGFRJ3 polyclonal antibody and the mouse 
anti-PY monoclonal antibody (4G10) were obtained from Upstate Bio- 
chemicals, Incorporated. 4G10 antibody was also supplied by D. Mor- 
risen. The mouse anti-Src monoclonal antibody 327 was purchased 
from Oncogene Science. 
Immunoblotting 
To assess the level of protein expression, cell lysates were electropho- 
resed in SDS-polyacrylamide gel and then transferred onto Immobilon 
P membranes (Millipore). Western blots were probed with the appro- 
priate antibodies. The anti-MT and anti-HA monoclonal antibodies 
were diluted at 1:2000. The remaining antibodies were diluted 1:1000. 
Horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse 
secondary antibodies (Boehringer Mannheim) were diluted 1:20,000. 
The bound secondary antibodies were detected by enhanced chemilu- 
minescence (Amersham). 
Immunocomplex Protein Kinase Assays and Gel Kinase Assays 
To assay for Akt protein kinase activity, cells were lysed in Nonidet 
P-40 (NP-40) lysis buffer (1% NP-40, 10% glycerol, 137 mM NaCI, 20 
mM Tris-HCI [pH 7.4]) containing 2 ~g/ml aprotinin, 2 p.g/ml leupeptin, 
1 mM phenylmethylsulfonyl fluoride, 20 mM NaF, 1 mM NaPPy, and 
1 mM NaiVe4. Lysates were precieared by centrifugation and then 
preabsorbed with Protein A-Protein G (2:1) agarose slurry. Immune- 
precipitation was carried out for 4 hr using anti-Akt-CT (1:500 dilution) 
or anti-HA (1:1000 dilution). Immunoprecipitates were washed three 
times with lysis buffer, once with water, and once with the Akt kinase 
buffer (20 mM HEPES-NaOH; 10 mM MgCI2, 10 mM MnCI2 [pH 7.4]). 
Kinase assays were carried out in Akt kinase buffer as previously 
described (Datta et al., 1995). Exogenous substrates were resus- 
pended in water at a concentration of 5 mg/ml. 
In gel kinase assays were carried out as previously described (Patri- 
otis et al., 1994). 
PI 3-Kinase Assays and Exposure of Akt Immunoprecipitates 
to Phosphorylated Phosphoinositides and Brain Extracts 
PI 3-kinase was immunoprecipitated from NP-40 lysates of NIH 3T3 
cells by use of the anti-PY monoclonal antibody 4G 10 (1:1000 dilution). 
PI 3-kinase activity in the immunoprecipitates was measured as de- 
scribed elsewhere (Whitman et al., 1987). 
PIP was produced preparatively by using anti-PY (1:1000 dilution) 
or anti-p85 immunoprecipitates (1:500 dilution) from PDGF-stimulated 
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NIH 3T3 cells and PI (Avanti Polar Lipids, Incorporated) as the sub- 
strate. PI was phosphorylated for 1 hr at room temperature. In vitro 
Akt protein kinase assays were carried out in the presence of PI, enzy- 
matically produced PIP, or PIP2 (Sigma). Before addition to the Akt 
immunoprecipitates at a final concentration of 0.02 mg/ml, the phos- 
pholipids were sonicated for 1 min in 30 mM HEPES-NaOH (pH 7.4) 
in a cup horn probe. For dose-response xperiments, PIP was serially 
diluted in PI (total phospholipid concentration, 0.02 mg/ml) prior to 
sonication. 
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